Hospital-acquired pneumonia
Better Tools for Fighting Gram-Negative Infections, but More Are Needed
Multidrug-resistant gram-negative bacteria are difficult to treat, but FDA approvals have increased the clinical ...
FEBRUARY 27, 2025
How Much Do We Know About Non-Ventilator HAP?
Better prevention of NV-HAP, the authors said, would improve patient care worldwide, while saving health systems ...
SEPTEMBER 13, 2024
Right Drug for the HABP and VABP Patient
Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia are among the most common and ...
AUGUST 23, 2023
Hospitalized Pneumonia Panel Detects Infection Far Earlier Than Culture
A new study has found that Unyvero multiplexed PCR diagnostic panels (OpGen) are able to detect pneumonia pathogens ...
AUGUST 2, 2022
FDA Grants HABP/VABP Indication for Zerbaxa
The FDA approved a new indication for ceftolozane-tazobactam to treat hospital-acquired bacterial pneumonia and ...
JUNE 3, 2019
Use Short Courses of Antibiotics To Treat HAP and VAP
HAP and VAP account for 20% to 25% of hospital-acquired infections, and may be fatal 10% to 15% of the time.
JULY 15, 2016
